Abstract
Lightening and depigmentation actives applied to the skin at home can be effective when associated with regular use of sunscreen, but they cannot offer good results in all cases. Complementary treatments performed in the office, such as peelings and lasers, have their responses linked to the experience of each dermatologist: some patients have good responses; others may even worsen their lesions. The experience of the authors treating scars and individuals with recalcitrant melasma with microneedles, with whitening in 100% of the cases and without the addition of any asset, led him to believe in the potential of needles as a whitening agent. This hypothesis was also validated by histopathological evaluations that present significant reduction of melanin granules in specimens stained by the Masson-Fontana method after which it was recommended as the Lima Protocol. PCI has been proposed as an effective treatment for IPH. In the author’s experience, when the methodology with all the recommended criteria is followed, the procedure always offers whitening. The number of sessions with an interval of 30 days depends on the intensity of BIPH, and there is no limit to the number of interventions. Moreover, according to the author’s experience, each intervention offers a gain in pigment reduction and improvement in skin quality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Sources
Bal SM, Caussin J, Pavel S, et al. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci. 2008;35:193–202.
Fernandes D. Minimally invasive percutaneous collagen induction. Oral Maxillofac Surg Clin North Am. 2005;17:51–63.
Gupta AK, Gover MD, Nouri K, et al. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55:1048–65.
Hsiao CY, Sung HC, Hu S, et al. Fractional CO2 laser treatment to enhance skin permeation of tranexamic acid with minimal skin disruption. Dermatology. 2015;230(3):269–75.
Lima EA. Microagulhamento em melasma facial recalcitrante: uma série de 22 casos. Na Bras Dermatol. 2015a;90(6):917–9.
Lima EA, Lima M, Takano D. Microneedling experimental study and classification of the resulting injury. Surg Cosmet Dermatol. 2013;5:110–4.
Lima EA. Microneedling in facial recalcitrant melasma: report of a series of 22 cases. An Bras Dermatol. 2015b;90(6):919–21.
Lima EVA, Lima MMDA, Paixão MP, et al. Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study. BMC Dermatology. 2017:1–6.
Lu YG, Liu J, Gao YH, et al. Modeling of transdermal drug delivery with a microneedle array. J Micromech Microeng. 2006;16:151–4.
Miot LD, Miot HA, Silva MG, et al. Physiopathology of melasma. An Bras Dermatol. 2009;84:623–35.
Orentreich DS, Orentreich N. Subcutaneous incisionless (subcision) surgery for the correction of depressed scars and wrinkles. Dermatol Surg. 1995;21:543–9.
Vachiramon V, Sahawatwong S, Sirithanabadeekul P. Treatment of melisma in men with low-fluence q-switched neodymium-doped yttrium-aluminumgarnet laser versus combined laser and glycolic acid peeling. Dermatol Surg. 2015;41:457–65.
Vandervoort J, Ludwig A. Microneedles for transdermal drug delivery; mini review. Front Biosci. 2008;13:1711–5.
Cassiano D, Esposito Lemos AC et al. Efficacy and safety of microneedling and oral tranexamic acid in the treatment of facial melasma in women: an open, evaluator-blinded, randomized clinical trial. J Am Acad Dermatol. 2020. pii: S0190-9622(20)30164-X.
Cassiano DP, Espósito ACC, Hassun KM, et al. Early clinical and histological changes induced by microneedling in facial melasma: a pilot study. Indian J Dermatol Venereol Leprol. 2019;85(6):638–41.
Espósito ACC, Brianezi G, de Souza NP, et al. Ultrastructural characterization of damage in the basement membrane of facial melasma. Arch Dermatol Res. 2020;312(3):223–7.
Handel AC, Miot LDB, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014;89(5):771–82.
Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228–37.
Ramaut L, Hoeksema H, Pirayesh A, et al. Microneedling: where do we stand now? A systematic review of the literature. J Plast Reconstr Aesthet Surg. 2018;71(1):1–14.
Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65(4):689–97.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lima, E., Lima, M. (2021). PCI Correcting Post-inflammatory Hyperpigmentation. In: Percutaneous Collagen Induction With Microneedling. Springer, Cham. https://doi.org/10.1007/978-3-030-57541-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-57541-0_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57540-3
Online ISBN: 978-3-030-57541-0
eBook Packages: MedicineMedicine (R0)